PRATESI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.265
EU - Europa 1.210
AS - Asia 203
AF - Africa 6
Totale 2.684
Nazione #
US - Stati Uniti d'America 1.258
PL - Polonia 700
RU - Federazione Russa 144
SE - Svezia 98
IE - Irlanda 95
IT - Italia 85
CN - Cina 49
SG - Singapore 44
HK - Hong Kong 43
JO - Giordania 34
GB - Regno Unito 29
FI - Finlandia 19
IN - India 13
VN - Vietnam 13
BE - Belgio 11
CH - Svizzera 9
CA - Canada 7
DE - Germania 7
TR - Turchia 6
CI - Costa d'Avorio 5
FR - Francia 4
ES - Italia 2
LV - Lettonia 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
MU - Mauritius 1
NL - Olanda 1
RO - Romania 1
TW - Taiwan 1
Totale 2.684
Città #
Warsaw 700
Fairfield 199
Ashburn 120
Chandler 114
Woodbridge 99
Dublin 95
Ann Arbor 85
Cambridge 85
Seattle 68
Houston 67
Wilmington 60
Lawrence 32
Singapore 32
Altamura 29
Beijing 29
Hong Kong 28
Princeton 28
Buffalo 21
Medford 18
Boardman 14
New York 14
Shanghai 13
Florence 12
Boston 10
Brussels 10
Dong Ket 10
Kent 10
Mumbai 10
Jacksonville 9
Los Angeles 7
Izmir 6
London 6
Phoenix 6
Abidjan 5
Bern 5
Dearborn 5
Falls Church 5
Norwalk 5
San Diego 5
Andover 4
Cagliari 4
Milan 4
Ottawa 4
Hillsboro 3
Morgantown 3
Ponti sul Mincio 3
Santa Clara 3
Toronto 3
Washington 3
Barcelona 2
Castelliri 2
Duncan 2
Hounslow 2
Pavia 2
Pune 2
Redwood City 2
Riga 2
Saint-Fons 2
Salerno 2
Tappahannock 2
Acton 1
Bethesda 1
Bremen 1
Bucharest 1
Giarre 1
Hanoi 1
Helsinki 1
Imola 1
Islington 1
Kilburn 1
Lappeenranta 1
Leawood 1
Miaoli 1
Naaldwijk 1
Nanjing 1
Napoli 1
New Bedfont 1
Old Bridge 1
Padova 1
Palo Alto 1
Prescot 1
Rignano 1
Rimini 1
Rome 1
San Mateo 1
Stevenage 1
Toulouse 1
Totale 2.159
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 254
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 253
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 226
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 219
LIGANDI SINTETICI DEL TLR7 E LORO APPLICAZIONE IN VIVO COME ADIUVANTI NEL TRATTAMENTO DELLE MALATTIE ALLERGICHE E DEI TUMORI 194
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 141
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 139
Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution 137
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 131
Assays and strategies for immunogenicity assessment of biological agents. 108
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 96
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. 94
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 93
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses 88
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 87
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 81
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 68
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 64
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 54
Pharmacological NAD-boosting strategies improve mitochondrial homeostasis in human complex i-mutant fibroblastss 52
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 49
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 48
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 41
Totale 2.717
Categoria #
all - tutte 7.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 18 46 74 64 62 73 56 47 57 4
2020/2021365 39 40 10 51 17 46 16 26 32 48 19 21
2021/2022188 3 16 17 3 10 7 4 18 11 11 39 49
2022/2023516 45 113 28 29 29 80 61 33 80 1 6 11
2023/2024189 10 21 20 11 17 36 14 36 3 2 14 5
2024/2025234 49 110 75 0 0 0 0 0 0 0 0 0
Totale 2.717